Recruiting
Bladder transitional cell carcinoma+3
RecruitingStudy on Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer to Reduce Need for Second Surgery
Registered drugNo placebo
Study on Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer to Reduce Need for Second Surgery
Registered drugNo placebo
- Disease:Bladder transitional cell carcinomaBladder transitional cell carcinoma recurrent+2
- Substances:Hexaminolevulinate
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Hexaminolevulinate
- Sponsor:Universita Degli Studi Di Roma La Sapienza